Navigation Links
Researchers pinpoint upper safe limit of vitamin D blood levels

Chevy Chase, MDResearchers claim to have calculated for the first time, the upper safe limit of vitamin D levels, above which the associated risk for cardiovascular events or death raises significantly, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

There is increasing evidence that vitamin D plays a pivotal role in human physiology. Vitamin D deficiency has been linked to cardiovascular events and mortality, but previous studies have found supplementation fails to decrease mortality or cardiovascular events, while other studies found only minor positive effects.

"The unpredictable results from previous studies may be due to the misconception that 'the higher the better,'" said Yosef Dror, PhD, of Hebrew University in Rehovot, Israel, and lead author of the study. "Although our study did not directly test the impact of vitamin D supplementation, we believe our results suggest it may be possible that only moderate supplementation within a narrow range of serum calcidiol (the main vitamin D fraction in the blood) will be associated with the most positive results."

Researchers conducted a study of 422,000 people aged 45 years or older, who underwent vitamin D blood assays. They found for the first time that the safe range of vitamin D levels with respect to coronary morbidity lies between 20 to 36 ng/mL. Vitamin D levels below and above this range adjusted rates of increased mortality and morbidity significantly.

More than 60 percent of the tested population had insufficient blood levels of vitamin D. Half of these subjects had severely low vitamin D levels which was associated with a 1.5 times increased risk of acute coronary morbidity or mortality. Three percent of those tested had elevated vitamin D levels above 36 ng/mL, which was associated with a 1.13 times elevated risk of coronary morbidity or death.

"Supplementing the entire population may jeopardize those found within the upper-normal range, shifting them to levels that are beyond the range associated with the lowest morbidity rates," said Dror. "Although we could not assess the impact of Vitamin D supplementation, our results may suggest that such supplementation to increase vitamin D blood levels, with strict monitoring to avoid overload, may have a significant influence on public health. This hypothesis still needs to be assessed in intervention trials."


Contact: Jenni Glenn Gingery
The Endocrine Society

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
3. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
4. UNH researchers find African farmers need better climate change data to improve farming practices
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. Researchers uncover molecular pathway through which common yeast becomes fungal pathogen
7. Researchers print live cells with a standard inkjet printer
8. Columbia Engineering and Penn researchers increase speed of single-molecule measurements
9. Researchers reveal how a single gene mutation leads to uncontrolled obesity
10. Researchers discover novel therapy for Crohns disease
11. New paper by Notre Dame researchers describes method for cleaning up nuclear waste
Post Your Comments:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... Nov. 2, 2015  SRI International has been awarded ... preclinical development services to the National Cancer Institute (NCI) ... provide scientific expertise, modern testing and support facilities, and ... pharmacology and toxicology studies to evaluate potential cancer prevention ... The PREVENT Cancer Drug Development Program is an NCI-supported ...
Breaking Biology News(10 mins):
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) ... a stockholder rights plan (Rights Plan) in an effort ... carryforwards (NOLs) under Section 382 of the Internal Revenue ... PharmAthene,s use of its NOLs could be substantially ... defined in Section 382 of the Code. In general, ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology: